Dr. Nick Warwick is the chief medical officer of ADVANZ PHARMA and has over 30 years of experience both in the pharmaceutical industry and as a medical doctor. Dr. Warwick trained as a medical doctor at Charing Cross Hospital Medical School in London (now part of the Imperial College group), qualifying in 1986. He spent 10 years in clinical medicine, rotating through several disciplines and primary care before joining the pharmaceutical industry in 1997 as medical adviser for Abbott.
In the following 24 years, Dr. Warwick has held senior country-level, regional, and global leadership roles within medical affairs and clinical development (Abbott and Abbvie) and was chief medical officer for Sandoz (2014-2019). In this role, he led a global team of medical, toxicology, and clinical experts delivering specialist input to generic development activities across Sandoz, was responsible for post-marketing clinical activities, strategic medical affairs partnerships with key global and regional franchises, and portfolio stewardship.
Dr. Warwick joined ADVANZ PHARMA as chief medical officer in June 2020. He is responsible for setting the medical vision and strategic direction for the medical office (comprising medical affairs, patient safety, clinical development, and medical compliance functions), ensuring that ADVANZ PHARMA has the right resources, skills, and capabilities to meet its strategic growth aspirations and base business needs and that the voice of the patient and healthcare professional is fully represented in all company decisions.
Dr. Warwick holds a Bachelor of Medicine, Bachelor of Surgery from Charing Cross Hospital Medical School, London (MBBS, 1986), and a Diploma from the Royal College of Obstetrics and Gynaecologists, London (DRCOG, 1992) and a Diploma of Pharmaceutical Medicine from the University of Wales, Cardiff (DPM, 1998). He has been a Fellow of the Faculty of Pharmaceutical Physicians (FFPM) since 2010.